Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGLNYSE:DVANASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLagilon health$2.97+2.6%$4.26$1.50▼$7.73$1.23B0.384.88 million shs4.12 million shsDVADaVita$144.29+0.4%$145.93$131.44▼$179.60$11.09B1.14817,444 shs1.28 million shsPGNYProgyny$22.00+3.8%$21.96$13.39▼$30.42$1.88B1.371.71 million shs1.61 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLagilon health+3.31%-27.77%-47.85%-13.81%-42.87%DVADaVita+0.47%+1.98%-7.20%-16.93%+4.92%PGNYProgyny+3.77%-5.98%-1.52%-1.74%-20.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLagilon health2.1335 of 5 stars4.12.00.00.02.10.00.6DVADaVita4.4084 of 5 stars2.03.00.04.53.51.73.1PGNYProgyny0.8154 of 5 stars1.22.00.00.02.21.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLagilon health 2.11Hold$4.8965.02% UpsideDVADaVita 2.00Hold$166.3315.28% UpsidePGNYProgyny 2.42Hold$23.456.61% UpsideCurrent Analyst Ratings BreakdownLatest DVA, AGL, and PGNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/8/2025AGLagilon healthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLagilon healthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.004/28/2025AGLagilon healthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLagilon healthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.004/15/2025AGLagilon healthCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/15/2025AGLagilon healthTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$3.50 ➝ $6.004/15/2025AGLagilon healthRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.004/8/2025AGLagilon healthSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$3.30 ➝ $8.503/31/2025PGNYProgynyBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$28.003/21/2025AGLagilon healthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLagilon health$5.99B0.20N/AN/A$1.63 per share1.82DVADaVita$12.82B0.87$18.91 per share7.63$4.95 per share29.15PGNYProgyny$1.17B1.61$0.62 per share35.58$5.77 per share3.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLagilon health-$262.60M-$0.59N/AN/AN/A-6.88%-47.84%-14.97%N/ADVADaVita$936.34M$10.7413.4311.351.077.31%115.48%4.94%N/APGNYProgyny$62.04M$0.5737.9333.852.395.03%11.36%7.87%N/ALatest DVA, AGL, and PGNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025AGLagilon health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion2/13/2025Q4 2024DVADaVita$2.14$2.24+$0.10$3.09$3.27 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLagilon health$1.8060.71%N/AN/A N/ADVADaVitaN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLagilon health0.061.291.29DVADaVita23.181.261.21PGNYProgynyN/A2.622.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLagilon healthN/ADVADaVita90.12%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipAGLagilon health3.20%DVADaVita2.00%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLagilon health650413.95 million398.83 millionNot OptionableDVADaVita70,00076.86 million78.40 millionOptionablePGNYProgyny31085.67 million74.68 millionOptionableDVA, AGL, and PGNY HeadlinesRecent News About These CompaniesCanaccord Genuity Group Has Lowered Expectations for Progyny (NASDAQ:PGNY) Stock PriceMay 13 at 1:56 AM | americanbankingnews.comProgyny, Inc. to Present at BofA Securities 2025 Health Care ConferenceMay 12 at 4:29 PM | gurufocus.comProgyny, Inc. to Present at BofA Securities 2025 Health Care Conference | PGNY Stock NewsMay 12 at 4:29 PM | gurufocus.comProgyny, Inc. to Present at BofA Securities 2025 Health Care ConferenceMay 12 at 3:58 PM | globenewswire.comFarallon Capital Management LLC Trims Stock Position in Progyny, Inc. (NASDAQ:PGNY)May 11 at 7:40 AM | marketbeat.comFirst Sabrepoint Capital Management LP Invests $9.66 Million in Progyny, Inc. (NASDAQ:PGNY)May 11 at 7:30 AM | marketbeat.comAlgert Global LLC Has $2.16 Million Stock Holdings in Progyny, Inc. (NASDAQ:PGNY)May 11 at 4:57 AM | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Hold" from BrokeragesMay 11 at 2:28 AM | marketbeat.comProgyny (NASDAQ:PGNY) Shares Down 8.4% on Disappointing EarningsMay 11 at 1:53 AM | americanbankingnews.comProgyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 10 at 9:25 AM | finance.yahoo.comFred Alger Management LLC Reduces Holdings in Progyny, Inc. (NASDAQ:PGNY)May 10 at 8:34 AM | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Cubist Systematic Strategies LLCMay 10 at 6:05 AM | marketbeat.comBrevan Howard Capital Management LP Invests $904,000 in Progyny, Inc. (NASDAQ:PGNY)May 10 at 5:39 AM | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Bought by Stifel Financial CorpMay 10 at 3:53 AM | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Bought by Dimensional Fund Advisors LPMay 10 at 3:44 AM | marketbeat.comPGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance RaisedMay 9, 2025 | msn.comProgyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next QuarterMay 9, 2025 | uk.finance.yahoo.comCorton Capital Inc. Invests $264,000 in Progyny, Inc. (NASDAQ:PGNY)May 9, 2025 | marketbeat.comProgyny, Inc. (PGNY) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comProgyny (PGNY) Tops Q1 Earnings and Revenue EstimatesMay 8, 2025 | zacks.comProgyny, Inc. Announces First Quarter 2025 ResultsMay 8, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAMD Stock Signals Strong Buy Ahead of EarningsBy Thomas Hughes | May 1, 2025View AMD Stock Signals Strong Buy Ahead of Earnings3 Retail Stocks That Desperately Need a Tariff BreakBy Chris Markoch | April 30, 2025View 3 Retail Stocks That Desperately Need a Tariff Break3 Bond ETFs for the Diversified InvestorBy Chris Markoch | April 13, 2025View 3 Bond ETFs for the Diversified InvestorAMD Relieves Market Despite Ongoing Share Price Outlook CautionBy Thomas Hughes | May 7, 2025View AMD Relieves Market Despite Ongoing Share Price Outlook CautionRetail Data Shows Urgency in Auto Parts: These 3 Stocks Could WinBy Gabriel Osorio-Mazilli | April 22, 2025View Retail Data Shows Urgency in Auto Parts: These 3 Stocks Could WinDVA, AGL, and PGNY Company Descriptionsagilon health NYSE:AGL$2.96 +0.08 (+2.60%) Closing price 05/12/2025 03:59 PM EasternExtended Trading$2.96 -0.01 (-0.20%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.DaVita NYSE:DVA$144.29 +0.53 (+0.37%) Closing price 05/12/2025 03:59 PM EasternExtended Trading$143.44 -0.84 (-0.59%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Progyny NASDAQ:PGNY$22.00 +0.81 (+3.82%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$21.88 -0.11 (-0.52%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
